These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9933049)

  • 1. Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group.
    Fawzy A; Vashi V; Chung M; Dias N; Gaffney M
    Urology; 1999 Feb; 53(2):329-35. PubMed ID: 9933049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.
    Kirby RS; Andersen M; Gratzke P; Dahlstrand C; Høye K
    BJU Int; 2001 Feb; 87(3):192-200. PubMed ID: 11167641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia.
    Kirby RS
    BJU Int; 2003 Jan; 91(1):41-4. PubMed ID: 12614248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morning versus evening dosing with doxazosin in benign prostatic hyperplasia: pharmacokinetics, efficacy and safety.
    Kirby RS
    Int J Clin Pract; 1998 Mar; 52(2):75-7. PubMed ID: 9624784
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM; Klarskov P
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men.
    Kirby RS
    Urology; 1995 Aug; 46(2):182-6. PubMed ID: 7542819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
    Kirby RS; O'Leary MP; Carson C
    BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.
    Gillenwater JY; Conn RL; Chrysant SG; Roy J; Gaffney M; Ice K; Dias N
    J Urol; 1995 Jul; 154(1):110-15. PubMed ID: 7539854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.
    Johnson TM; Burrows PK; Kusek JW; Nyberg LM; Tenover JL; Lepor H; Roehrborn CG;
    J Urol; 2007 Nov; 178(5):2045-50; discussion 2050-1. PubMed ID: 17869295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial.
    Kirby RS; Roehrborn C; Boyle P; Bartsch G; Jardin A; Cary MM; Sweeney M; Grossman EB;
    Urology; 2003 Jan; 61(1):119-26. PubMed ID: 12559281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.
    Goldsmith DR; Plosker GL
    Drugs; 2005; 65(14):2037-47. PubMed ID: 16162024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.
    Türkeri LN; Ozyürek M; Ersev D; Akdaş A
    Arch Esp Urol; 2001 Mar; 54(2):191-6. PubMed ID: 11341128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of doxazosin in men with benign prostatic hyperplasia: urodynamic assessment.
    Ozbey I; Aksoy Y; Polat O; Biçgi O; Demirel A; Okyar G
    Int Urol Nephrol; 1999; 31(4):471-9. PubMed ID: 10668942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study.
    Bendix Holme J; Christensen MM; Rasmussen PC; Jacobsen F; Nielsen J; Nørgaard JP; Olesen S; Noer I; Wolf H; Elkjaer Husted S
    Scand J Urol Nephrol; 1994 Mar; 28(1):77-82. PubMed ID: 7516576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study.
    Christensen MM; Bendix Holme J; Rasmussen PC; Jacobsen F; Nielsen J; Nørgaard JP; Olesen S; Noer I; Wolf H; Husted SE
    Scand J Urol Nephrol; 1993; 27(1):39-44. PubMed ID: 7684157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study.
    Fawzy A; Braun K; Lewis GP; Gaffney M; Ice K; Dias N
    J Urol; 1995 Jul; 154(1):105-9. PubMed ID: 7539853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of doxazosin on the symptoms of benign prostatic hyperplasia: results from three double-blind placebo-controlled studies.
    Mobley DF; Kaplan S; Ice K; Gaffney M; Dias N
    Int J Clin Pract; 1997; 51(5):282-8. PubMed ID: 9489085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.